On July 22, The Annals of Thoracic Surgery published this consensus statement on nomenclature and classification of the congenital bicuspid aortic valve (BAV) and Its aortopathy.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy for Clinical, Surgical, Interventional and Research Purposes
July 22, 2021
June 4, 2021
On May 25, 2021, Dr. David Heimansohn successfully performed the first surgical implantation of biopolymer Tria™ heart valve in a patient with mitral valve disease at Ascension St. Vincent Hospital, Indianapolis, IN.
May 21, 2021
A large RCT concluding that 'surgical occlusion of the left atrial appendage provides additional protection against stroke when added to anticoagulation.' A number of limitations are briefly discussed. Findings are interesting in that absolute absence of surgical complications has been declared.
April 15, 2021
This study, conducted at the Cleveland Clinic, investigated reports of failure of the Trifecta externally wrapped, bovine pericardial aortic valve prosthesis (Abbott Laboratories, Abbott Park, IL). Concerns were raised about the long-term Trifecta durability.
July 3, 2020
The authors make a brief overview of tricuspid regurgitation associated with congenital heart defects, including morphology, incidence and echocardiographic evaluation. The status quo of medical and surgical managements and outcomes are also comprehensively reviewed.
Design, Development, Testing at ISO Standards and In Vivo Feasibility Study of a Novel Polymeric Heart Valve Prosthesis
June 30, 2020
Researchers from the UK reported a novel polymeric heart valve, PoliValve, which is made entirely from styrenic block copolymers.
Edwards Lifesciences' Every Heartbeat Matters Philanthropic Initiative Expanding To Reach More Patients
February 24, 2020
In 2014, Edwards Lifescience launched an ambitious philanthropic initiative called Every Heartbeat Matters (EHM) with the goal of impacting the global burden of heart valve disease through the education, screening and treatment of 1 million underserved people by 2020.
January 8, 2020
A medium size RCT with encouraging surgical outcomes in the era of TAVI expansion.....
August 9, 2019
Retrospectively using a longitudinal echocardiography database, the authors analyzed the data of 3,276 patients with isolated severe tricuspids regurgitation (TR) from 2001 through 2016. Of these patients, 5% underwent tricuspid valve surgery.
July 31, 2019
The right lateral access for minimally invasive aortic valve surgery is a superior concept, leaving the sternum and ribs untouched and allowing an unbeatable cosmetic result.